Last news
LDRA Makes MISRA C:2023 Compliance Accessible to Every Safety - and Security - Critical Development Team

LDRA Makes MISRA C:2023 Compliance Accessible to Every Safety - and Security - Critical Development Team

...

JinenU Solar Will Make Its Debut at PV EXPO 2023, Focus on Solar Module Customization, Service Worldwide With a Capacity of 20GW

JinenU Solar Will Make Its Debut at PV EXPO 2023, Focus on Solar Module Customization, Service Worldwide With a Capacity of 20GW

...

First 210mm n-type monocrystalline ingot rolls off production line at Trina Solar Qinghai Factory

First 210mm n-type monocrystalline ingot rolls off production line at Trina Solar Qinghai Factory

...

LG UNVEILS ENERGY EFFICIENT HEATING SOLUTIONS DESIGNED TO MEET DIVERSE CUSTOMER NEEDS AT ISH 2023

LG UNVEILS ENERGY EFFICIENT HEATING SOLUTIONS DESIGNED TO MEET DIVERSE CUSTOMER NEEDS AT ISH 2023

...

Qritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image Management

Qritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image Management

...

LIPS Unveils PCIe Endpoint-Mode 3DxAI Edge Accelerator Targeting Low-Latency Robotic Vision, Powered by NVIDIA Jetson AGX Xavier

LIPS Unveils PCIe Endpoint-Mode 3DxAI Edge Accelerator Targeting Low-Latency Robotic Vision, Powered by NVIDIA Jetson AGX Xavier

...

Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy

Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy

...

AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy's Disease Treatment

AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy's Disease Treatment

...

menu
menu